Deutsche Cannabis AAQS 2024
Deutsche Cannabis AAQS
0
Тикер
HEMP.F
ISIN
DE000A0BVVK7
WKN
A0BVVK
Deutsche Cannabis ima trenutni AAQS od 0. Visok AAQS može se smatrati pozitivnim pokazateljem da se preduzeće uspešno razvija. Investitori mogu očekivati da je kompanija na dobrom putu da ostvari dobit. S druge strane, važno je posmatrati AAQS deonice Deutsche Cannabis u poređenju sa ostvarenom dobiti i drugim preduzećima iste branše. Visok AAQS nije apsolutna garancija za pozitivnu budućnost. Samo tako se može dobiti kompletna slika o performansama kompanije. Da bi se bolje procenio razvoj preduzeća, važno je posmatrati AAQS u poređenju sa drugim kompanijama iste branše. Generalno, investitori bi uvek trebali da posmatraju AAQS kompanije u kontekstu sa drugim finansijskim pokazateljima kao što su dobit, EBIT, Cash Flow i drugi, kako bi doneli obrazovane odluke o investiranju.
Deutsche Cannabis Aktienanalyse
Šta radi Deutsche Cannabis?
The German Cannabis AG is a rising company that specializes in the production and sale of medical cannabis. The company was founded in 2018 and is headquartered in Frankfurt am Main. The history of the German Cannabis AG began when a group of investors came together to invest in the growing market for medical cannabis. They recognized the potential that cannabis has as a medical product and the growing demand for high-quality cannabis. The founders of the company made it their mission to breed the best hemp varieties and extract the active ingredients in order to deliver the highest possible quality to their customers. The business model of the German Cannabis AG is based on growing and distributing medical cannabis. The company has its own plantation in Portugal, where it grows cannabis in modern greenhouses. The cultivation area is currently around 30 hectares and is planned to be expanded in the future. The company is committed to meeting the highest quality standards and therefore relies on state-of-the-art technologies and processes. For example, only organic-certified seeds are used to ensure optimal quality and purity of the end product. The German Cannabis AG offers various divisions to meet the different needs of customers. These divisions include not only medical cannabis but also CBD products, cosmetics, and dietary supplements. In the medical cannabis division, the company seeks to provide doctors and patients with high-quality and reliable products. The individual needs and specific requirements are the main focus. The company produces various products such as oils, capsules, flowers, or extracts that are tailored to the needs of patients. These products are sold exclusively to pharmacies and are available by prescription only. The CBD products division includes oils, cosmetics, and dietary supplements based on cannabidiol (CBD). These products are legal and can be purchased online or in specialty stores without a prescription. The company also places great emphasis on quality and reliability in this division and conducts intensive research and development. The cosmetics division includes various products such as creams, ointments, and balms based on medical cannabis. These are specifically offered for the treatment of skin problems such as eczema, psoriasis, or skin inflammation. Natural ingredients are used, and synthetic products are avoided. The dietary supplements division is characterized by high-quality products such as capsules, powders, or oils enriched with medical cannabis. These products support the immune system, digestion, and overall vitality of the body. In summary, the German Cannabis AG is a rising company specializing in the production and sale of medical cannabis and related products. Quality and reliability are the focus, and intensive investment is made in research and development. The different divisions offer customers a wide range of products that are individually tailored to their needs. Deutsche Cannabis ist eines der beliebtesten Unternehmen auf Eulerpool.com.Često postavljana pitanja o Deutsche Cannabis akciji
Plansovi za štednju u akcijama nude atraktivnu mogućnost za investitore da dugoročno izgrade bogatstvo. Jedna od glavnih prednosti je takozvani efekat prosečne cene: investiranjem redovnog fiksnog iznosa u akcije ili fondove akcija, automatski se kupuju više deonica kada su cene niske i manje kada su visoke. To može dovesti do povoljnijeg prosečnog cena po deonici tokom vremena. Pored toga, plansovi za štednju u akcijama omogućuju čak i malim ulagačima pristup skupim akcijama, pošto je moguće učestvovati već sa malim iznosima. Redovno investiranje takođe podstiče disciplinovanu strategiju ulaganja i pomaže da se izbegnu emocionalne odluke, kao što su impulsivno kupovanje ili prodaja. Osim toga, investitori profitiraju od potencijalnog povećanja vrednosti akcija kao i od isplata dividendi, koje se mogu reinvestirati, što pojačava efekat kamate na kamatu i time rast investiranog kapitala.
Akcija Deutsche Cannabis je dostupna za štedne planove kod sledećih provajdera: Trade Republic
Andere Kennzahlen von Deutsche Cannabis
Naša analiza akcija za akciju Deutsche Cannabis Promet uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Deutsche Cannabis Promet. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize:
- Deutsche Cannabis Promet
- Deutsche Cannabis Dobit
- Deutsche Cannabis KGV
- Deutsche Cannabis KUV
- Deutsche Cannabis EBIT
- Deutsche Cannabis Dividenda
- Deutsche Cannabis Akcije
- Deutsche Cannabis Kapitalizacija tržišta
- Deutsche Cannabis Dugovanje
- Deutsche Cannabis Obaveze
- Deutsche Cannabis Kapital društva
- Deutsche Cannabis AAQS
- Deutsche Cannabis zaposleni
- Deutsche Cannabis ROE
- Deutsche Cannabis ROA
- Deutsche Cannabis ROCE